Early Detection Biomarkers for Ovarian Cancer | Zendy

Sreeja Sarojini | Zendy; Ayala Tamir | Zendy; Heejin Lim | Zendy; Shihong Li | Zendy; Shifang Zhang | Zendy; André Goy | Zendy; Andrew L. Pecora | Zendy; K. Stephen Suh | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Early Detection Biomarkers for Ovarian Cancer

Author(s) -

Sreeja Sarojini,

Ayala Tamir,

Heejin Lim,

Shihong Li,

Shifang Zhang,

André Goy,

Andrew L. Pecora,

K. Stephen Suh

Publication year - 2012

Publication title -

journal of oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.228

H-Index - 54

eISSN - 1687-8469

pISSN - 1687-8450

DOI - 10.1155/2012/709049

Subject(s) - ovarian cancer , medicine , biomarker , disease , malignancy , cancer , oncology , carcinogenesis , biology , biochemistry

Despite the widespread use of conventional and contemporary methods to detect ovarian cancer development, ovarian cancer remains a common and commonly fatal gynecological malignancy. The identification and validation of early detection biomarkers highly specific to ovarian cancer, which would permit development of minimally invasive screening methods for detecting early onset of the disease, are urgently needed. Current practices for early detection of ovarian cancer include transvaginal ultrasonography, biomarker analysis, or a combination of both. In this paper we review recent research on novel and robust biomarkers for early detection of ovarian cancer and provide specific details on their contributions to tumorigenesis. Promising biomarkers for early detection of ovarian cancer include KLK6/7, GSTT1, PRSS8, FOLR1, ALDH1, and miRNAs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research